Assessment of burden of Malaria in Gwanda district, Zimbabwe, using the disability adjusted life years

International Journal of Environmental Research and Public Health

Volumn 13, Issue 2, 2016, Pages

  Gunda, Resign ^a   Chimbari, Moses John ^a   Mukaratirwa, Samson ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Disability adjusted life year; Disease burden; Gwanda District; Malaria; Zimbabwe

Indexed keywords

DISABILITY; DISEASE SPREAD; HEALTH STATUS; MALARIA; MORBIDITY; MORTALITY; POLICY MAKING;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEATH; DISABILITY ADJUSTED LIFE YEARS CALCULATION; FEMALE; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MATHEMATICAL ANALYSIS; MIDDLE AGED; NEWBORN; PARASITE LOAD; PARASITE TRANSMISSION; PUBLIC HEALTH; QUALITY OF LIFE ASSESSMENT; REMISSION; SCHISTOSOMIASIS; TIME SERIES ANALYSIS; ZIMBABWE; COST OF ILLNESS; DISABLED PERSON; PRESCHOOL CHILD; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; REGISTER; VERY ELDERLY; YOUNG ADULT;

GWANDA; MATABELELAND SOUTH; ZIMBABWE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DISABLED PERSONS; FEMALE; HUMANS; INFANT; MALARIA; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT; ZIMBABWE;

EID: 84975784731     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13020244     Document Type: Article

References (63)

1. Walker, N.F.; Nadjim, B.; Whitty, C.J.M. Malaria. Medicine 2009, 38, 41-46. [CrossRef]
2. Abay, S.M.; Tilahun, M.; Fikrie, N.; Habtewold, A. Plasmodium falciparum and Schistosoma mansoni coinfection and the side benefit of artemether-lumefantrine in malaria patients. J. Infect. Dev. Ctries 2013, 7, 468-474. [CrossRef] [PubMed]
3. Tonnang, H.E.; Kangalawe, R.Y.; Yanda, P.Z. Predicting and mapping malaria under climate change scenarios: The potential redistribution of malaria vectors in Africa. Malar. J. 2010, 9, 111. [CrossRef] [PubMed]
4. Kumar, A.; Valecha, N.; Jain, T.; Dash, A.P. Burden of malaria in India: Retrospective and prospective view. Am. J. Trop. Med. Hyg. 2007, 77, 69-78. [PubMed]
5. WHO. World Malaria Report; WHO: Geneva, Switzerland, 2014.
6. Brooker, S.; Akhwale, W.; Pullan, R.; Estambale, B.; Clarke, S.E.; Sonw, R.W.; Hotez, P.J. Epidemiology of plasmodium-helminth co-infection in Africa: Populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 2007, 77, 88-98. [PubMed]
7. Booth, M.; Graham, A.; Viney, M. Parasitic co-infections: Challenges and solutions. Parasitology 2008, 135, 749. [CrossRef] [PubMed]
8. Fernando, S.D.; Rodrigo, C.; Rajapakse, S. The "hidden" burden of malaria: Cognitive impairment following infection. Malar. J. 2010, 9, 366. [CrossRef] [PubMed]
9. Bener, A.; Zirie, M.A.; Kim, E.J.; Al Buz, R.; Zaza, M.; Al-Nufal, M.; Basma, B.; Edward, W.H.; Elio, R. Measuring burden of diseases in a rapidly developing economy: State of Qatar. Glob. J. Health Sci. 2013, 5, 134-144. [CrossRef] [PubMed]
10. Murray, C.J.; Lopez, A.D. The Global Burden of Disease; WHO: Geneva Switzerland, 1998; pp. 1-46.
11. Donev, D.; Zaletel-Kragelj, L.; Bjegovic, V.; Burazeri, G. Measuring the burden of disease: Disability Adjusted Life Year (DALY). In Methods and Tools in Public Health: A Handbook for Teachers, Researchers and Health Professionals; Zaletel-Kragelj, L., Botikov, J., Eds.; Lage: Hans Jacobs Publishing Company: Lage, Germany, 2010.
12. Murray, C.J.L.; Ezzati, M.; Flaxman, A.D.; Lim, S.; Lozano, R.; Michaud, C.; Naghavi, M.; Salomon, J.A.; Shibuya, K.; Vos, T.; et al. GBD 2010: Design, definitions, and metrics. Lancet 2012, 380, 2063-2066. [CrossRef]
13. Murray, C.J.L.; Vos, T.; Lozano, R.; Naghavi, M.; Flaxman, A.D.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.A.; Abdalla, S.; et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012, 380, 2197-2223. [CrossRef]
14. Gibney, K.; Sinclair, M.; O'Toole, J.; Leder, K. Using disability-adjusted life years to set health-based targets: A novel use of an established burden of disease metric. J. Public Health Policy 2013, 34, 439-446. [CrossRef] [PubMed]
15. Longfield, K.; Smith, B.; Gray, R.; Ngamkitpaiboon, L.; Vielot, N. Putting health metrics into practice: Using the disability-adjusted life year for strategic decision making. BMC Public Health 2013, 13, S2. [CrossRef] [PubMed]
16. Sassi, F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006, 21, 402-408. [CrossRef] [PubMed]
17. Haque, U.; Overgaard, H.J.; Clements, A.C.A.; Norris, D.E.; Islam, N.; Karim, J.; Roy, S.; Haque, W.; Kabir, M.; Smith, D.L.; et al. Malaria burden and control in Bangladesh and prospects for elimination: An epidemiological and economic assessment. Lancet. Glob. Health. 2014, 2, e98-e105. [CrossRef]
18. Mharakurwa, S. Plasmodium falciparum transmission rate and selection for drug resistance: A vexed association or a key to successful control? Int. J. Parasitol. 2004, 34, 1483-1487. [CrossRef] [PubMed]
19. Munhenga, G.; Masendu, H.T.; Brooke, B.D.; Hunt, R.H.; Koekemoer, L.K. Pyrethroid resistance in the major malaria vector Anopheles arabiensis from Gwave, a malaria-endemic area in Zimbabwe. Malar. J. 2008, 7, 247. [CrossRef] [PubMed]
20. Mabaso, M.L.; Craig, M.; Vounatsou, P.; Smith, T. Towards empirical description of malaria seasonality in southern Africa: The example of Zimbabwe. Trop. Med. Int. Health 2005, 10, 909-918. [CrossRef] [PubMed]
21. Mharakurwa, S.; Mutambu, S.L.; Mberikunashe, J.; Thuma, P.E.; Moss,W.J.; Mason, P.R.; For the Southern Africa ICEMR Team. Changes in the burden of malaria following scale up of malaria control interventions in Mutasa District, Zimbabwe. Malar. J. 2013, 12, 223. [CrossRef] [PubMed]
22. Soko, W.; Chimbari, M.J.; Mukaratirwa, S. Insecticide resistance in malaria-transmitting mosquitoes in Zimbabwe: A Review. Infect. Dis. Poverty 2015, 4, 46. [CrossRef] [PubMed]
23. Mlambo, G.; Sullivan, D.; Mutambu, S.L.; Soko,W.; Mbedzi, J.; Chivenga, J.; Gemperli, A.; Kumar, N. High prevalence of molecular markers for resistance to chloroquine and pyrimethamine in Plasmodium falciparum from Zimbabwe. Parasitol. Res. 2007, 101, 1147-1151. [CrossRef] [PubMed]
24. USAID. Zimbabwe Malaria Operational Plan; USAID:Washington, DC, USA, 2015.
25. O'Meara, W.P.; Mangeni, J.N.; Steketee, R.; Greenwood, B. Changes in the burden of malaria in sub-Saharan Africa. Lancet. Infect. Dis. 2010, 10, 545-555. [CrossRef]
26. Cibulskis, R.E.; Bell, D.; Christophel, E.M.; Hii, J.; Delacollette, C.; Bakyaita, N.; Aregawi, M.W. Estimating trends in the burden of malaria at country level. Am. J. Trop. Med. Hyg. 2007, 77, 133-137. [PubMed]
27. Alonso, P.L.; Brown, G.; Arevalo-Herrera, M.; Binka, F.; Chitnis, C.; Collins, F.; Doumbo, O.K.; Greenwood, B.; Hall, B.F.; Levine, M.M.; et al. A research agenda to underpin malaria eradication. PLoS Med. 2011, 8, e1000406. [CrossRef] [PubMed]
28. Devleesschauwer, B.; Ale, A.; Torgerson, P.; Praet, N.; De Noordhout, C.M.; Pandey, B.D.; Pun, S.B.; Lake, R.; Vercruysse, J.; Joshi, D.D.; et al. The burden of parasitic zoonoses in Nepal: A systematic review. PLoS Negl. Trop. Dis. 2014, 8, e2634. [CrossRef] [PubMed]
29. Chapman, G.; Hansen, K.S.; Jelsma, J.; Ndhlovu, C.; Piotti, B.; Byskov, J.; Vos, T. The burden of disease in Zimbabwe in 1997 as measured by disability-adjusted life years lost. Trop. Med. Int. Health 2006, 11, 660-671. [CrossRef] [PubMed]
30. ZIMSTAT. Census 2012 Report; ZIMSTAT: Harare, Zimbabwe, 2012.
31. Deressa,W.; Hailemariam, D.; Ali, A. Economic costs of epidemic malaria to households in rural Ethiopia. Trop. Med. Int. Health 2007, 12, 1148-1156. [CrossRef] [PubMed]
32. WHO. Global Health Observatory Data. Available online: http//www.who.int/gho/mortality_burden _disease/life_tables/en (accessed on 20 May 2015).
33. Fox-Rushby, J.A.; Hanson, K. Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis. Health Policy Plan. 2001, 16, 326-331. [CrossRef] [PubMed]
34. Prüss-Üstün, A.; Mathers, C.; Corvalan, C.; Woodward, A. Introduction and Methods: Assessing the Environmental Burden of Disease at National and Local Levels, in WHO Environmental Burden of Disease; WHO: Geneva, Switzerland, 2003.
35. WHO. Metrics: Disability-Adjusted Life Year (DALY) Quantifying the Burden of Disease from Mortality and Morbidity. Available online: http://www.who.int/healthinfo/global_burden_disease/ metrics_daly/en/index.html (accessed on 17 September 2014).
36. Jankovic, H. Summary measures of population health and their relevance for health policy. In Public Health Strategies. A Handbook for Teachers, Researchers, Health Professionals and Decision Makers; Galan, A., Scintee, G., Eds.; Lage: Hans Jacobs Publishing Company: Lage, Germany, 2005.
37. Anand, S.; Hanson, K. Disability-adjusted life years: A critical review. J. Health Econ. 1997, 16, 685-702. [CrossRef]
38. WHO. DisabilityWeights, Discounting and AgeWeighting of DALYs. Available online: http://www.who.int/ healthinfo/global_burden_disease/metrics_daly/en/ (accessed on 1 June 2015).
39. Abdalla, S.I.; Malik, E.M.; Ali, K.M. The burden of malaria in Sudan: Incidence, mortality and disability-adjusted life-years. Malar. J. 2007, 6, 97. [CrossRef] [PubMed]
40. Guinovart, C.; Bassat, Q.; Sigauque, B.; Aide, P.; Sacarlal, J.; Nhampossa, T.; Bardaji, A.; Nhacolo, A.; Macete, E.; Mandomando, I.; et al. Malaria in rural Mozambique. Part I: Children attending the outpatient clinic. Malar. J. 2008, 7, 36. [CrossRef] [PubMed]
41. Spencer, S. Global burden of disease 2010 study: A personal reflection. Glob. Cardiol. Sci. Pract. 2013, 2013, 115-126. [CrossRef] [PubMed]
42. Hackett, F.; Ford, L.B.; Fevre, E.; Simarro, P. Incorporating scale dependence in disease burden estimates: The case of human African trypanosomiasis in Uganda. PLoS Negl. Trop. Dis. 2014, 8, e2704. [CrossRef] [PubMed]
43. Budke, C.M.; Jiamin, Q.; Zinsstag, J.; Qian, W.; Torgerson, P.R. Use of disability adjusted life years in the estimation of the disease burden of echinococcosis for a high endemic region of the Tibetan plateau. Am. J. Trop. Med. Hyg. 2004, 71, 56-64. [PubMed]
44. Clark, D.V.; Mammen, M.P., Jr.; Nisalak, A.; Puthimethee, V.; Endy, T.P. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am. J. Trop. Med. Hyg. 2005, 72, 786-791. [PubMed]
45. Fevre, E.M.; Odiit, M.; Coleman, P.G.;Woolhouse, M.E.J.;Welbrun, S.C. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. BMC Public Health 2008, 8, 96. [CrossRef] [PubMed]
46. Luz, P.M.; Grinsztejn, B.; Galvani, A.P. Disability adjusted life years lost to dengue in Brazil. Trop. Med. Int. Health. 2009, 14, 237-246. [CrossRef] [PubMed]
47. Matemba, L.E.; Fevre, E.M.; Kibona, S.N.; Picozzi, K.; Cleaveland, S.; Shaw, A.P.; Welburn, S.C. Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania. PLoS Negl. Trop. Dis. 2010, 4, e868. [CrossRef] [PubMed]
48. Meltzer, M.I.; Rigau-Perez, J.G.; Clark, G.G.; Reiter, P.; Gubler, D.J. Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am. J. Trop. Med. Hyg. 1998, 59, 265-271. [PubMed]
49. Praet, N.; Speybroeck, N.; Manzanedo, R.; Berkverns, D.; Nforninwe, D.N.; Zoli, A.; Quet, F.; Preux, P.M.; Carabin, H.; Geerts, S. The disease burden of Taenia solium cysticercosis in Cameroon. PLoS Negl. Trop. Dis. 2009, 3, e406. [CrossRef] [PubMed]
50. Krishnamoorthy, K.; Harichandrakumar, K.T.; Kumari, A.K.; Das, L.K. Burden of chikungunya in India: Estimates of Disability Adjusted Life Years (DALY) lost in 2006 epidemic. J. Vector Borne Dis. 2009, 46, 26-35. [PubMed]
51. Shepard, D.S.; EUndurraga, A.; Halasa, Y.A. Economic and disease burden of dengue in Southeast Asia. PLoS Negl. Trop. Dis. 2013, 7, e2055. [CrossRef] [PubMed]
52. Byass, P. Making sense of long-term changes in malaria. Lancet 2008, 372, 1523-1525. [CrossRef]
53. Seo, M.K.; Baker, P.; Ngo, K.N. Cost-effectiveness analysis of vaccinating children in Malawi with RTS, S vaccines in comparison with long-lasting insecticide-treated nets. Malar. J. 2014, 13, 66. [CrossRef] [PubMed]
54. Pfeil, J.; Borrmann, S.; Tozan, Y. Dihydroartemisinin-piperaquine vs. artemether-lumefantrine for first-line treatment of uncomplicated malaria in African children: A cost-effectiveness analysis. PLoS ONE 2014, 9, e95681. [CrossRef] [PubMed]
55. Mueller, D.H.; Wiseman, V.; Bakusa, D.; Morgah, K.; Dare, A.; Tchamdja, P. Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo integrated child health campaign. Malar. J. 2008, 7, 73. [CrossRef] [PubMed]
56. Lubell, Y.; Riewpaiboon, A.; Dondorp, A.M.; Von Seidlein, L.; Mokuolu, O.A.; Nansumba, M.; Gesase, S.; Kent, A.; Mtove, G.; Olaosebikan, R.; et al. Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa. Bull. WHO 2011, 89, 504-512. [CrossRef] [PubMed]
57. Becker-Dreps, S.I.; Biddle, A.K.; Pettifor, A.; Musuamba, G.; Imbie, D.N.; Meshnick, S.; Behets, F. Cost-effectiveness of adding bed net distribution for malaria prevention to antenatal services in Kinshasa, Democratic Republic of the Congo. Am. J. Trop. Med. Hyg. 2009, 81, 496-502. [PubMed]
58. Utzinger, J.; Tozan, Y.; Singer, B.H. Efficacy and cost-effectiveness of environmental management for malaria control. Trop. Med. Int. Health 2001, 6, 677-687. [CrossRef] [PubMed]
59. Tozan, Y.; Klein, E.Y.; Darley, S.; Panicker, R.; Laxminarayan, R.; Breman, J.G. Prereferral rectal artesunate for treatment of severe childhood malaria: A cost-effectiveness analysis. Lancet 2010, 376, 1910-1915. [CrossRef]
60. Hutton, G.; Schellenberg, D.; Tediosi, F.; Macete, E.; Kahigwa, E.; Sigauque, B.; Mas, X.; Trapero, M.; Tanner, M.; Trilla, A.; et al. Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull. WHO 2009, 87, 123-129. [PubMed]
61. Ross, A.; Maire, N.; Sicuri, E.; Smith, T.; Conteh, L. Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children. PLoS ONE 2011, 6, e18391. [CrossRef] [PubMed]
62. Akhavan, D.; Musgrove, P.; Abrantes, A.; Gusmao, R. Cost-effective malaria control in Brazil. Cost-effectiveness of a Malaria Control Program in the Amazon Basin of Brazil, 1988-1996. Soc. Sci. Med. 1999, 49, 1385-1399. [CrossRef]
63. Goodman, C.A.; Coleman, P.G.; Mills, A.J. Cost-effectiveness of malaria control in sub-Saharan Africa. Lancet 1999, 354, 378-385. [CrossRef]